Pnc Financial Services Group, Inc. Rocket Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $156 Billion
- Q3 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 16,113 shares of RCKT stock, worth $181,110. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,113
Previous 15,536
3.71%
Holding current value
$181,110
Previous $334,000
11.08%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding RCKT
# of Institutions
213Shares Held
93.1MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$199 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$126 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$69.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.54MShares$62.2 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.49MShares$50.5 Million0.39% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $851M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...